April 2025
1. MA D, Dai LJ, Wu XR, Liu CL, et al
   Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer.
   Cancer Cell. 2025 Apr 4:S1535-6108(25)00118-7. doi: 10.1016/j.ccell.2025.
   

   >> Share

   
   March 2025
2. PALMER CL, Boras B, Pascual B, Li N, et al
   CDK4 selective inhibition improves preclinical anti-tumor efficacy and safety.
   Cancer Cell. 2025;43:464-481.
   

   >> Share

   
   
3. LIU T, Ellisen LW
   Exploring the "chemo" in chemoimmunotherapy for triple-negative breast cancer.
   Cancer Cell. 2025;43:332-334.
   

   >> Share

   
   February 2025
4. DENKERT C, Rachakonda S, Karn T, Weber K, et al
   Dynamics of molecular heterogeneity in high-risk luminal breast cancer-From intrinsic to adaptive subtyping.
   Cancer Cell. 2025;43:232-247.
   

   >> Share

   
   
5. BIANCHINI G, Viale G, Dugo M
   From intrinsic to adaptive clusters in breast cancer.
   Cancer Cell. 2025;43:171-173.
   

   >> Share

   
   January 2025
6. ZHANG Y, Chen H, Mo H, Zhao N, et al
   Distinct cellular mechanisms underlie chemotherapies and PD-L1 blockade combinations in triple-negative breast cancer.
   Cancer Cell. 2025 Jan 30:S1535-6108(25)00025-X. doi: 10.1016/j.ccell.2025.
   

   >> Share

   
   
7. YANG Z, Liu X, Zhu J, Chai Y, et al
   Inhibiting intracellular CD28 in cancer cells enhances antitumor immunity and overcomes anti-PD-1 resistance via targeting PD-L1.
   Cancer Cell. 2025;43:86-102.
   

   >> Share

   
   December 2024
8. HANGGI K, Li J, Gangadharan A, Liu X, et al
   Interleukin-1alpha release during necrotic-like cell death generates myeloid-driven immunosuppression that restricts anti-tumor immunity.
   Cancer Cell. 2024;42:2015-2031.
   

   >> Share

   
   November 2024
9. KUDO R, Safonov A, Jones C, Moiso E, et al
   Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion.
   Cancer Cell. 2024;42:1983.
   

   >> Share

   
   
10. YAN P, Jimenez ER, Li Z, Bui T, et al
    Midkine as a driver of age-related changes and increase in mammary tumorigenesis.
    Cancer Cell. 2024;42:1936-1954.
    

    >> Share

    
    October 2024
11. KUDO R, Safonov A, Jones C, Moiso E, et al
    Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion.
    Cancer Cell. 2024 Oct 4:S1535-6108(24)00357-X. doi: 10.1016/j.ccell.2024.
    

    >> Share

    
    September 2024
12. VISVADER JE
    Midkine links aging with breast cancer-A new predictor of cancer risk.
    Cancer Cell. 2024 Sep 30:S1535-6108(24)00351-9. doi: 10.1016/j.ccell.2024.
    

    >> Share

    
    
13. GAN S, Macalinao DG, Shahoei SH, Tian L, et al
    Distinct tumor architectures and microenvironments for the initiation of breast cancer metastasis in the brain.
    Cancer Cell. 2024 Sep 12:S1535-6108(24)00314-3. doi: 10.1016/j.ccell.2024.
    

    >> Share

    
    
14. BOON M, Akkari L
    Architecture sets the path: Breast cancer subtypes differently shape the early brain metastatic niche.
    Cancer Cell. 2024 Sep 12:S1535-6108(24)00320-9. doi: 10.1016/j.ccell.2024.
    

    >> Share

    
    June 2024
15. ELKHOLI IE, Rose AAN, Aguirre-Ghiso JA, Cote JF, et al
    How can we integrate the biology of breast cancer cell dormancy into clinical practice?
    Cancer Cell. 2024 Jun 12:S1535-6108(24)00191-0. doi: 10.1016/j.ccell.2024.
    

    >> Share

    
    
16. LI Y, Huang M, Wang M, Wang Y, et al
    Tumor cells impair immunological synapse formation via central nervous system-enriched metabolite.
    Cancer Cell. 2024;42:985-1002.
    

    >> Share

    
    May 2024
17. MCGINNIS CS, Miao Z, Superville D, Yao W, et al
    The temporal progression of lung immune remodeling during breast cancer metastasis.
    Cancer Cell. 2024 May 24:S1535-6108(24)00167-3. doi: 10.1016/j.ccell.2024.
    

    >> Share

    
    
18. LAYER N, Bunse L, Venkataramani V
    Neural deception: Breast cancer co-opts neuronal mechanisms to evade the immune system.
    Cancer Cell. 2024 May 17:S1535-6108(24)00170-3. doi: 10.1016/j.ccell.2024.
    

    >> Share

    
    April 2024
19. LIN CJ, Jin X, Ma D, Chen C, et al
    Genetic interactions reveal distinct biological and therapeutic implications in breast cancer.
    Cancer Cell. 2024;42:701-719.
    

    >> Share

    
    March 2024
20. BEJARANO L, Kauzlaric A, Lamprou E, Lourenco J, et al
    Interrogation of endothelial and mural cells in brain metastasis reveals key immune-regulatory mechanisms.
    Cancer Cell. 2024;42:378-395.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share